PTX 2.56% 3.8¢ prescient therapeutics limited

Ann: Extension of Share Purchase Plan, page-21

  1. 114 Posts.
    lightbulb Created with Sketch. 34
    Absolutely will be as quoted by Peter Mac's Professor Darcy, whom is now part of our Scientific Advisory Board: -

    Professor Darcy said. “Another exciting development involves the OmniCAR platform. This approach may pave the way for a new generation of CAR-T cells that are capable of being controllable, targeting multiple antigens, and potentially used as an off-the-shelf product. I am excited to be able to participate in this important work for cancer patients.”

    Cheers,

    AMS
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $30.60M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $47.91K 1.256M

Buyers (Bids)

No. Vol. Price($)
11 881755 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 150000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.